id	sid	tid	token	lemma	pos
cord-339919-4ko4lwjz	1	1	key	key	NN
cord-339919-4ko4lwjz	1	2	:	:	:
cord-339919-4ko4lwjz	2	1	cord-339919	cord-339919	NN
cord-339919-4ko4lwjz	2	2	-	-	HYPH
cord-339919-4ko4lwjz	2	3	4ko4lwjz	4ko4lwjz	JJ
cord-339919-4ko4lwjz	2	4	authors	author	NNS
cord-339919-4ko4lwjz	2	5	:	:	:
cord-339919-4ko4lwjz	2	6	Cook	cook	VB
cord-339919-4ko4lwjz	2	7	,	,	,
cord-339919-4ko4lwjz	2	8	T.	T.	NNP
cord-339919-4ko4lwjz	2	9	M.	M.	NNP
cord-339919-4ko4lwjz	2	10	title	title	NN
cord-339919-4ko4lwjz	2	11	:	:	:
cord-339919-4ko4lwjz	2	12	The	the	DT
cord-339919-4ko4lwjz	2	13	importance	importance	NN
cord-339919-4ko4lwjz	2	14	of	of	IN
cord-339919-4ko4lwjz	2	15	hypertension	hypertension	NN
cord-339919-4ko4lwjz	2	16	as	as	IN
cord-339919-4ko4lwjz	2	17	a	a	DT
cord-339919-4ko4lwjz	2	18	risk	risk	NN
cord-339919-4ko4lwjz	2	19	factor	factor	NN
cord-339919-4ko4lwjz	2	20	for	for	IN
cord-339919-4ko4lwjz	2	21	severe	severe	JJ
cord-339919-4ko4lwjz	2	22	illness	illness	NN
cord-339919-4ko4lwjz	2	23	and	and	CC
cord-339919-4ko4lwjz	2	24	mortality	mortality	NN
cord-339919-4ko4lwjz	2	25	in	in	IN
cord-339919-4ko4lwjz	2	26	COVID‐19	COVID‐19	NNP
cord-339919-4ko4lwjz	2	27	date	date	NN
cord-339919-4ko4lwjz	2	28	:	:	:
cord-339919-4ko4lwjz	2	29	2020	2020	CD
cord-339919-4ko4lwjz	2	30	-	-	HYPH
cord-339919-4ko4lwjz	2	31	05	05	CD
cord-339919-4ko4lwjz	2	32	-	-	HYPH
cord-339919-4ko4lwjz	2	33	09	09	CD
cord-339919-4ko4lwjz	2	34	journal	journal	NN
cord-339919-4ko4lwjz	2	35	:	:	:
cord-339919-4ko4lwjz	3	1	Anaesthesia	anaesthesia	NN
cord-339919-4ko4lwjz	3	2	DOI	DOI	NNP
cord-339919-4ko4lwjz	3	3	:	:	:
cord-339919-4ko4lwjz	4	1	10.1111	10.1111	CD
cord-339919-4ko4lwjz	4	2	/	/	SYM
cord-339919-4ko4lwjz	4	3	anae.15103	anae.15103	NNP
cord-339919-4ko4lwjz	4	4	sha	sha	NNP
cord-339919-4ko4lwjz	4	5	:	:	:
cord-339919-4ko4lwjz	4	6	f11862cbda2818f602fc67dbcd5594e8e674e903	f11862cbda2818f602fc67dbcd5594e8e674e903	NNP
cord-339919-4ko4lwjz	4	7	doc_id	doc_id	CD
cord-339919-4ko4lwjz	4	8	:	:	:
cord-339919-4ko4lwjz	4	9	339919	339919	CD
cord-339919-4ko4lwjz	4	10	cord_uid	cord_uid	NNS
cord-339919-4ko4lwjz	4	11	:	:	:
cord-339919-4ko4lwjz	4	12	4ko4lwjz	4ko4lwjz	LS
cord-339919-4ko4lwjz	5	1	The	the	DT
cord-339919-4ko4lwjz	5	2	virus	virus	NN
cord-339919-4ko4lwjz	5	3	responsible	responsible	JJ
cord-339919-4ko4lwjz	5	4	for	for	IN
cord-339919-4ko4lwjz	5	5	COVID-19	COVID-19	NNP
cord-339919-4ko4lwjz	5	6	binds	bind	NNS
cord-339919-4ko4lwjz	5	7	to	to	IN
cord-339919-4ko4lwjz	5	8	the	the	DT
cord-339919-4ko4lwjz	5	9	angiotensin	angiotensin	NN
cord-339919-4ko4lwjz	5	10	converting	convert	VBG
cord-339919-4ko4lwjz	5	11	enzyme-2	enzyme-2	NNP
cord-339919-4ko4lwjz	5	12	(	(	-LRB-
cord-339919-4ko4lwjz	5	13	ACE-2	ACE-2	NNP
cord-339919-4ko4lwjz	5	14	)	)	-RRB-
cord-339919-4ko4lwjz	5	15	receptor	receptor	NN
cord-339919-4ko4lwjz	5	16	[	[	-LRB-
cord-339919-4ko4lwjz	5	17	1	1	CD
cord-339919-4ko4lwjz	5	18	]	]	-RRB-
cord-339919-4ko4lwjz	5	19	.	.	.
cord-339919-4ko4lwjz	6	1	Several	several	JJ
cord-339919-4ko4lwjz	6	2	articles	article	NNS
cord-339919-4ko4lwjz	6	3	have	have	VBP
cord-339919-4ko4lwjz	6	4	noted	note	VBN
cord-339919-4ko4lwjz	6	5	that	that	IN
cord-339919-4ko4lwjz	6	6	hypertension	hypertension	NN
cord-339919-4ko4lwjz	6	7	is	be	VBZ
cord-339919-4ko4lwjz	6	8	a	a	DT
cord-339919-4ko4lwjz	6	9	risk	risk	NN
cord-339919-4ko4lwjz	6	10	factor	factor	NN
cord-339919-4ko4lwjz	6	11	for	for	IN
cord-339919-4ko4lwjz	6	12	COVID-19	covid-19	ADD
cord-339919-4ko4lwjz	6	13	[	[	-LRB-
cord-339919-4ko4lwjz	6	14	2	2	CD
cord-339919-4ko4lwjz	6	15	-	-	SYM
cord-339919-4ko4lwjz	6	16	7	7	CD
cord-339919-4ko4lwjz	6	17	]	]	-RRB-
cord-339919-4ko4lwjz	6	18	.	.	.
cord-339919-4ko4lwjz	7	1	It	-PRON-	PRP
cord-339919-4ko4lwjz	7	2	is	be	VBZ
cord-339919-4ko4lwjz	7	3	currently	currently	RB
cord-339919-4ko4lwjz	7	4	difficult	difficult	JJ
cord-339919-4ko4lwjz	7	5	to	to	TO
cord-339919-4ko4lwjz	7	6	distinguish	distinguish	VB
cord-339919-4ko4lwjz	7	7	between	between	IN
cord-339919-4ko4lwjz	7	8	hypertension	hypertension	NN
cord-339919-4ko4lwjz	7	9	as	as	IN
cord-339919-4ko4lwjz	7	10	an	an	DT
cord-339919-4ko4lwjz	7	11	independent	independent	JJ
cord-339919-4ko4lwjz	7	12	risk	risk	NN
cord-339919-4ko4lwjz	7	13	factor	factor	NN
cord-339919-4ko4lwjz	7	14	in	in	IN
cord-339919-4ko4lwjz	7	15	COVID-19	COVID-19	NNP
cord-339919-4ko4lwjz	7	16	from	from	IN
cord-339919-4ko4lwjz	7	17	one	one	CD
cord-339919-4ko4lwjz	7	18	that	that	WDT
cord-339919-4ko4lwjz	7	19	co	co	NN
cord-339919-4ko4lwjz	7	20	-	-	VB
cord-339919-4ko4lwjz	7	21	varies	vary	VBZ
cord-339919-4ko4lwjz	7	22	with	with	IN
cord-339919-4ko4lwjz	7	23	other	other	JJ
cord-339919-4ko4lwjz	7	24	patient	patient	NN
cord-339919-4ko4lwjz	7	25	factors	factor	NNS
cord-339919-4ko4lwjz	7	26	such	such	JJ
cord-339919-4ko4lwjz	7	27	as	as	IN
cord-339919-4ko4lwjz	7	28	age	age	NN
cord-339919-4ko4lwjz	7	29	and	and	CC
cord-339919-4ko4lwjz	7	30	cardiovascular	cardiovascular	JJ
cord-339919-4ko4lwjz	7	31	disease	disease	NN
cord-339919-4ko4lwjz	7	32	.	.	.
cord-339919-4ko4lwjz	8	1	It	-PRON-	PRP
cord-339919-4ko4lwjz	8	2	is	be	VBZ
cord-339919-4ko4lwjz	8	3	difficult	difficult	JJ
cord-339919-4ko4lwjz	8	4	from	from	IN
cord-339919-4ko4lwjz	8	5	individual	individual	JJ
cord-339919-4ko4lwjz	8	6	reports	report	NNS
cord-339919-4ko4lwjz	8	7	to	to	TO
cord-339919-4ko4lwjz	8	8	determine	determine	VB
cord-339919-4ko4lwjz	8	9	whether	whether	IN
cord-339919-4ko4lwjz	8	10	hypertension	hypertension	NN
cord-339919-4ko4lwjz	8	11	is	be	VBZ
cord-339919-4ko4lwjz	8	12	a	a	DT
cord-339919-4ko4lwjz	8	13	risk	risk	NN
cord-339919-4ko4lwjz	8	14	factor	factor	NN
cord-339919-4ko4lwjz	8	15	for	for	IN
cord-339919-4ko4lwjz	8	16	development	development	NN
cord-339919-4ko4lwjz	8	17	of	of	IN
cord-339919-4ko4lwjz	8	18	symptomatic	symptomatic	JJ
cord-339919-4ko4lwjz	8	19	disease	disease	NN
cord-339919-4ko4lwjz	8	20	or	or	CC
cord-339919-4ko4lwjz	8	21	hospitalisation	hospitalisation	NN
cord-339919-4ko4lwjz	8	22	or	or	CC
cord-339919-4ko4lwjz	8	23	for	for	IN
cord-339919-4ko4lwjz	8	24	more	more	RBR
cord-339919-4ko4lwjz	8	25	severe	severe	JJ
cord-339919-4ko4lwjz	8	26	disease	disease	NN
cord-339919-4ko4lwjz	8	27	.	.	.
cord-339919-4ko4lwjz	9	1	Reviewing	review	VBG
cord-339919-4ko4lwjz	9	2	the	the	DT
cord-339919-4ko4lwjz	9	3	literature	literature	NN
cord-339919-4ko4lwjz	9	4	that	that	WDT
cord-339919-4ko4lwjz	9	5	reports	report	VBZ
cord-339919-4ko4lwjz	9	6	rates	rate	NNS
cord-339919-4ko4lwjz	9	7	of	of	IN
cord-339919-4ko4lwjz	9	8	hypertension	hypertension	NN
cord-339919-4ko4lwjz	9	9	amongst	amongst	IN
cord-339919-4ko4lwjz	9	10	included	include	VBN
cord-339919-4ko4lwjz	9	11	patients	patient	NNS
cord-339919-4ko4lwjz	9	12	indicates	indicate	VBZ
cord-339919-4ko4lwjz	9	13	a	a	DT
cord-339919-4ko4lwjz	9	14	consistent	consistent	JJ
cord-339919-4ko4lwjz	9	15	association	association	NN
cord-339919-4ko4lwjz	9	16	with	with	IN
cord-339919-4ko4lwjz	9	17	more	more	RBR
cord-339919-4ko4lwjz	9	18	severe	severe	JJ
cord-339919-4ko4lwjz	9	19	disease	disease	NN
cord-339919-4ko4lwjz	9	20	and	and	CC
cord-339919-4ko4lwjz	9	21	increased	increase	VBN
cord-339919-4ko4lwjz	9	22	mortality	mortality	NN
cord-339919-4ko4lwjz	9	23	.	.	.
cord-339919-4ko4lwjz	9	24	.	.	.
cord-339919-4ko4lwjz	10	1	It	-PRON-	PRP
cord-339919-4ko4lwjz	10	2	is	be	VBZ
cord-339919-4ko4lwjz	10	3	currently	currently	RB
cord-339919-4ko4lwjz	10	4	difficult	difficult	JJ
cord-339919-4ko4lwjz	10	5	to	to	TO
cord-339919-4ko4lwjz	10	6	distinguish	distinguish	VB
cord-339919-4ko4lwjz	10	7	between	between	IN
cord-339919-4ko4lwjz	10	8	hypertension	hypertension	NN
cord-339919-4ko4lwjz	10	9	as	as	IN
cord-339919-4ko4lwjz	10	10	an	an	DT
cord-339919-4ko4lwjz	10	11	independent	independent	JJ
cord-339919-4ko4lwjz	10	12	risk	risk	NN
cord-339919-4ko4lwjz	10	13	factor	factor	NN
cord-339919-4ko4lwjz	10	14	in	in	IN
cord-339919-4ko4lwjz	10	15	COVID-19	COVID-19	NNP
cord-339919-4ko4lwjz	10	16	from	from	IN
cord-339919-4ko4lwjz	10	17	one	one	CD
cord-339919-4ko4lwjz	10	18	that	that	WDT
cord-339919-4ko4lwjz	10	19	co	co	NN
cord-339919-4ko4lwjz	10	20	-	-	VB
cord-339919-4ko4lwjz	10	21	varies	vary	VBZ
cord-339919-4ko4lwjz	10	22	with	with	IN
cord-339919-4ko4lwjz	10	23	other	other	JJ
cord-339919-4ko4lwjz	10	24	patient	patient	NN
cord-339919-4ko4lwjz	10	25	factors	factor	NNS
cord-339919-4ko4lwjz	10	26	such	such	JJ
cord-339919-4ko4lwjz	10	27	as	as	IN
cord-339919-4ko4lwjz	10	28	age	age	NN
cord-339919-4ko4lwjz	10	29	and	and	CC
cord-339919-4ko4lwjz	10	30	cardiovascular	cardiovascular	JJ
cord-339919-4ko4lwjz	10	31	disease	disease	NN
cord-339919-4ko4lwjz	10	32	.	.	.
cord-339919-4ko4lwjz	11	1	It	-PRON-	PRP
cord-339919-4ko4lwjz	11	2	is	be	VBZ
cord-339919-4ko4lwjz	11	3	difficult	difficult	JJ
cord-339919-4ko4lwjz	11	4	from	from	IN
cord-339919-4ko4lwjz	11	5	individual	individual	JJ
cord-339919-4ko4lwjz	11	6	reports	report	NNS
cord-339919-4ko4lwjz	11	7	to	to	TO
cord-339919-4ko4lwjz	11	8	determine	determine	VB
cord-339919-4ko4lwjz	11	9	whether	whether	IN
cord-339919-4ko4lwjz	11	10	hypertension	hypertension	NN
cord-339919-4ko4lwjz	11	11	is	be	VBZ
cord-339919-4ko4lwjz	11	12	a	a	DT
cord-339919-4ko4lwjz	11	13	risk	risk	NN
cord-339919-4ko4lwjz	11	14	factor	factor	NN
cord-339919-4ko4lwjz	11	15	for	for	IN
cord-339919-4ko4lwjz	11	16	development	development	NN
cord-339919-4ko4lwjz	11	17	of	of	IN
cord-339919-4ko4lwjz	11	18	symptomatic	symptomatic	JJ
cord-339919-4ko4lwjz	11	19	disease	disease	NN
cord-339919-4ko4lwjz	11	20	or	or	CC
cord-339919-4ko4lwjz	11	21	hospitalisation	hospitalisation	NN
cord-339919-4ko4lwjz	11	22	or	or	CC
cord-339919-4ko4lwjz	11	23	for	for	IN
cord-339919-4ko4lwjz	11	24	more	more	RBR
cord-339919-4ko4lwjz	11	25	severe	severe	JJ
cord-339919-4ko4lwjz	11	26	disease	disease	NN
cord-339919-4ko4lwjz	11	27	.	.	.
cord-339919-4ko4lwjz	12	1	Reviewing	review	VBG
cord-339919-4ko4lwjz	12	2	The	the	DT
cord-339919-4ko4lwjz	12	3	prevalence	prevalence	NN
cord-339919-4ko4lwjz	12	4	of	of	IN
cord-339919-4ko4lwjz	12	5	hypertension	hypertension	NN
cord-339919-4ko4lwjz	12	6	in	in	IN
cord-339919-4ko4lwjz	12	7	China	China	NNP
cord-339919-4ko4lwjz	12	8	is	be	VBZ
cord-339919-4ko4lwjz	12	9	approximately	approximately	RB
cord-339919-4ko4lwjz	12	10	23	23	CD
cord-339919-4ko4lwjz	12	11	%	%	NN
cord-339919-4ko4lwjz	12	12	[	[	-LRB-
cord-339919-4ko4lwjz	12	13	8	8	CD
cord-339919-4ko4lwjz	12	14	]	]	-RRB-
cord-339919-4ko4lwjz	12	15	and	and	CC
cord-339919-4ko4lwjz	12	16	in	in	IN
cord-339919-4ko4lwjz	12	17	Italy	Italy	NNP
cord-339919-4ko4lwjz	12	18	,	,	,
cord-339919-4ko4lwjz	12	19	26	26	CD
cord-339919-4ko4lwjz	12	20	%	%	NN
cord-339919-4ko4lwjz	12	21	[	[	-LRB-
cord-339919-4ko4lwjz	12	22	9	9	CD
cord-339919-4ko4lwjz	12	23	]	]	-RRB-
cord-339919-4ko4lwjz	12	24	.	.	.
cord-339919-4ko4lwjz	13	1	These	these	DT
cord-339919-4ko4lwjz	13	2	reports	report	NNS
cord-339919-4ko4lwjz	13	3	therefore	therefore	RB
cord-339919-4ko4lwjz	13	4	do	do	VBP
cord-339919-4ko4lwjz	13	5	not	not	RB
cord-339919-4ko4lwjz	13	6	provide	provide	VB
cord-339919-4ko4lwjz	13	7	robust	robust	JJ
cord-339919-4ko4lwjz	13	8	evidence	evidence	NN
cord-339919-4ko4lwjz	13	9	as	as	IN
cord-339919-4ko4lwjz	13	10	to	to	IN
cord-339919-4ko4lwjz	13	11	whether	whether	IN
cord-339919-4ko4lwjz	13	12	hypertension	hypertension	NN
cord-339919-4ko4lwjz	13	13	is	be	VBZ
cord-339919-4ko4lwjz	13	14	a	a	DT
cord-339919-4ko4lwjz	13	15	risk	risk	NN
cord-339919-4ko4lwjz	13	16	factor	factor	NN
cord-339919-4ko4lwjz	13	17	for	for	IN
cord-339919-4ko4lwjz	13	18	developing	develop	VBG
cord-339919-4ko4lwjz	13	19	symptomatic	symptomatic	JJ
cord-339919-4ko4lwjz	13	20	COVID-19	COVID-19	NNP
cord-339919-4ko4lwjz	13	21	requiring	require	VBG
cord-339919-4ko4lwjz	13	22	hospitalisation	hospitalisation	NN
cord-339919-4ko4lwjz	13	23	.	.	.
cord-339919-4ko4lwjz	14	1	Yang	Yang	NNP
cord-339919-4ko4lwjz	14	2	et	et	NNP
cord-339919-4ko4lwjz	14	3	al	al	NNP
cord-339919-4ko4lwjz	14	4	.	.	.
cord-339919-4ko4lwjz	15	1	[	[	-LRB-
cord-339919-4ko4lwjz	15	2	10	10	CD
cord-339919-4ko4lwjz	15	3	]	]	-RRB-
cord-339919-4ko4lwjz	15	4	reported	report	VBD
cord-339919-4ko4lwjz	15	5	that	that	DT
cord-339919-4ko4lwjz	15	6	hypertension	hypertension	NN
cord-339919-4ko4lwjz	15	7	was	be	VBD
cord-339919-4ko4lwjz	15	8	not	not	RB
cord-339919-4ko4lwjz	15	9	more	more	RBR
cord-339919-4ko4lwjz	15	10	common	common	JJ
cord-339919-4ko4lwjz	15	11	in	in	IN
cord-339919-4ko4lwjz	15	12	those	those	DT
cord-339919-4ko4lwjz	15	13	in	in	IN
cord-339919-4ko4lwjz	15	14	China	China	NNP
cord-339919-4ko4lwjz	15	15	with	with	IN
cord-339919-4ko4lwjz	15	16	COVID-19	covid-19	CD
cord-339919-4ko4lwjz	15	17	than	than	IN
cord-339919-4ko4lwjz	15	18	the	the	DT
cord-339919-4ko4lwjz	15	19	general	general	JJ
cord-339919-4ko4lwjz	15	20	population	population	NN
cord-339919-4ko4lwjz	15	21	.	.	.
cord-339919-4ko4lwjz	16	1	However	however	RB
cord-339919-4ko4lwjz	16	2	,	,	,
cord-339919-4ko4lwjz	16	3	in	in	IN
cord-339919-4ko4lwjz	16	4	all	all	PDT
cord-339919-4ko4lwjz	16	5	the	the	DT
cord-339919-4ko4lwjz	16	6	above	above	JJ
cord-339919-4ko4lwjz	16	7	reports	report	NNS
cord-339919-4ko4lwjz	16	8	,	,	,
cord-339919-4ko4lwjz	16	9	hypertension	hypertension	NN
cord-339919-4ko4lwjz	16	10	is	be	VBZ
cord-339919-4ko4lwjz	16	11	notably	notably	RB
cord-339919-4ko4lwjz	16	12	associated	associate	VBN
cord-339919-4ko4lwjz	16	13	with	with	IN
cord-339919-4ko4lwjz	16	14	poor	poor	JJ
cord-339919-4ko4lwjz	16	15	outcome	outcome	NN
cord-339919-4ko4lwjz	16	16	from	from	IN
cord-339919-4ko4lwjz	16	17	COVID-19	COVID-19	NNP
cord-339919-4ko4lwjz	16	18	.	.	.
cord-339919-4ko4lwjz	17	1	The	the	DT
cord-339919-4ko4lwjz	17	2	current	current	JJ
cord-339919-4ko4lwjz	17	3	data	datum	NNS
cord-339919-4ko4lwjz	17	4	do	do	VBP
cord-339919-4ko4lwjz	17	5	not	not	RB
cord-339919-4ko4lwjz	17	6	clarify	clarify	VB
cord-339919-4ko4lwjz	17	7	the	the	DT
cord-339919-4ko4lwjz	17	8	mechanism	mechanism	NN
cord-339919-4ko4lwjz	17	9	of	of	IN
cord-339919-4ko4lwjz	17	10	this	this	DT
cord-339919-4ko4lwjz	17	11	increased	increase	VBN
cord-339919-4ko4lwjz	17	12	risk	risk	NN
cord-339919-4ko4lwjz	17	13	,	,	,
cord-339919-4ko4lwjz	17	14	for	for	IN
cord-339919-4ko4lwjz	17	15	instance	instance	NN
cord-339919-4ko4lwjz	17	16	whether	whether	IN
cord-339919-4ko4lwjz	17	17	it	-PRON-	PRP
cord-339919-4ko4lwjz	17	18	is	be	VBZ
cord-339919-4ko4lwjz	17	19	due	due	JJ
cord-339919-4ko4lwjz	17	20	to	to	IN
cord-339919-4ko4lwjz	17	21	hypertension	hypertension	NN
cord-339919-4ko4lwjz	17	22	itself	-PRON-	PRP
cord-339919-4ko4lwjz	17	23	or	or	CC
cord-339919-4ko4lwjz	17	24	treatment	treatment	NN
cord-339919-4ko4lwjz	17	25	,	,	,
cord-339919-4ko4lwjz	17	26	nor	nor	CC
cord-339919-4ko4lwjz	17	27	whether	whether	IN
cord-339919-4ko4lwjz	17	28	it	-PRON-	PRP
cord-339919-4ko4lwjz	17	29	is	be	VBZ
cord-339919-4ko4lwjz	17	30	associated	associate	VBN
cord-339919-4ko4lwjz	17	31	with	with	IN
cord-339919-4ko4lwjz	17	32	the	the	DT
cord-339919-4ko4lwjz	17	33	use	use	NN
cord-339919-4ko4lwjz	17	34	of	of	IN
cord-339919-4ko4lwjz	17	35	ACE	ace	NN
cord-339919-4ko4lwjz	17	36	inhibitors	inhibitor	NNS
cord-339919-4ko4lwjz	17	37	and	and	CC
cord-339919-4ko4lwjz	17	38	angiotensin-2	angiotensin-2	NNP
cord-339919-4ko4lwjz	17	39	type	type	NN
cord-339919-4ko4lwjz	17	40	-	-	:
cord-339919-4ko4lwjz	17	41	I	i	NN
cord-339919-4ko4lwjz	17	42	receptor	receptor	NN
cord-339919-4ko4lwjz	17	43	blockers	blocker	NNS
cord-339919-4ko4lwjz	17	44	,	,	,
cord-339919-4ko4lwjz	17	45	though	though	IN
cord-339919-4ko4lwjz	17	46	this	this	DT
cord-339919-4ko4lwjz	17	47	has	have	VBZ
cord-339919-4ko4lwjz	17	48	been	be	VBN
cord-339919-4ko4lwjz	17	49	previously	previously	RB
cord-339919-4ko4lwjz	17	50	suggested	suggest	VBN
cord-339919-4ko4lwjz	17	51	[	[	-LRB-
cord-339919-4ko4lwjz	17	52	11	11	CD
cord-339919-4ko4lwjz	17	53	]	]	-RRB-
cord-339919-4ko4lwjz	17	54	.	.	.
cord-339919-4ko4lwjz	18	1	The	the	DT
cord-339919-4ko4lwjz	18	2	limitation	limitation	NN
cord-339919-4ko4lwjz	18	3	of	of	IN
cord-339919-4ko4lwjz	18	4	this	this	DT
cord-339919-4ko4lwjz	18	5	analysis	analysis	NN
cord-339919-4ko4lwjz	18	6	is	be	VBZ
cord-339919-4ko4lwjz	18	7	that	that	IN
cord-339919-4ko4lwjz	18	8	in	in	IN
cord-339919-4ko4lwjz	18	9	several	several	JJ
cord-339919-4ko4lwjz	18	10	of	of	IN
cord-339919-4ko4lwjz	18	11	the	the	DT
cord-339919-4ko4lwjz	18	12	studies	study	NNS
cord-339919-4ko4lwjz	18	13	,	,	,
cord-339919-4ko4lwjz	18	14	final	final	JJ
cord-339919-4ko4lwjz	18	15	patient	patient	NN
cord-339919-4ko4lwjz	18	16	outcomes	outcome	NNS
cord-339919-4ko4lwjz	18	17	are	be	VBP
cord-339919-4ko4lwjz	18	18	uncertain	uncertain	JJ
cord-339919-4ko4lwjz	18	19	as	as	IN
cord-339919-4ko4lwjz	18	20	patients	patient	NNS
cord-339919-4ko4lwjz	18	21	'	'	POS
cord-339919-4ko4lwjz	18	22	hospitalisation	hospitalisation	NN
cord-339919-4ko4lwjz	18	23	or	or	CC
cord-339919-4ko4lwjz	18	24	ICU	ICU	NNP
cord-339919-4ko4lwjz	18	25	stay	stay	NN
cord-339919-4ko4lwjz	18	26	has	have	VBZ
cord-339919-4ko4lwjz	18	27	not	not	RB
cord-339919-4ko4lwjz	18	28	been	be	VBN
cord-339919-4ko4lwjz	18	29	completed	complete	VBN
cord-339919-4ko4lwjz	18	30	.	.	.
cord-339919-4ko4lwjz	19	1	Hypertension	hypertension	NN
cord-339919-4ko4lwjz	19	2	is	be	VBZ
cord-339919-4ko4lwjz	19	3	included	include	VBN
cord-339919-4ko4lwjz	19	4	in	in	IN
cord-339919-4ko4lwjz	19	5	many	many	JJ
cord-339919-4ko4lwjz	19	6	reports	report	NNS
cord-339919-4ko4lwjz	19	7	as	as	IN
cord-339919-4ko4lwjz	19	8	a	a	DT
cord-339919-4ko4lwjz	19	9	'	'	``
cord-339919-4ko4lwjz	19	10	risk	risk	NN
cord-339919-4ko4lwjz	19	11	factor	factor	NN
cord-339919-4ko4lwjz	19	12	'	'	''
cord-339919-4ko4lwjz	19	13	for	for	IN
cord-339919-4ko4lwjz	19	14	COVID-19	COVID-19	NNP
cord-339919-4ko4lwjz	19	15	but	but	CC
cord-339919-4ko4lwjz	19	16	there	there	EX
cord-339919-4ko4lwjz	19	17	has	have	VBZ
cord-339919-4ko4lwjz	19	18	been	be	VBN
cord-339919-4ko4lwjz	19	19	a	a	DT
cord-339919-4ko4lwjz	19	20	lack	lack	NN
cord-339919-4ko4lwjz	19	21	of	of	IN
cord-339919-4ko4lwjz	19	22	clarity	clarity	NN
cord-339919-4ko4lwjz	19	23	as	as	IN
cord-339919-4ko4lwjz	19	24	to	to	IN
cord-339919-4ko4lwjz	19	25	whether	whether	IN
cord-339919-4ko4lwjz	19	26	this	this	DT
cord-339919-4ko4lwjz	19	27	means	mean	VBZ
cord-339919-4ko4lwjz	19	28	risk	risk	NN
cord-339919-4ko4lwjz	19	29	factor	factor	NN
cord-339919-4ko4lwjz	19	30	for	for	IN
cord-339919-4ko4lwjz	19	31	acquiring	acquire	VBG
cord-339919-4ko4lwjz	19	32	the	the	DT
cord-339919-4ko4lwjz	19	33	disease	disease	NN
cord-339919-4ko4lwjz	19	34	,	,	,
cord-339919-4ko4lwjz	19	35	the	the	DT
cord-339919-4ko4lwjz	19	36	severity	severity	NN
cord-339919-4ko4lwjz	19	37	of	of	IN
cord-339919-4ko4lwjz	19	38	disease	disease	NN
cord-339919-4ko4lwjz	19	39	or	or	CC
cord-339919-4ko4lwjz	19	40	for	for	IN
cord-339919-4ko4lwjz	19	41	poor	poor	JJ
cord-339919-4ko4lwjz	19	42	outcomes	outcome	NNS
cord-339919-4ko4lwjz	19	43	.	.	.
cord-339919-4ko4lwjz	20	1	It	-PRON-	PRP
cord-339919-4ko4lwjz	20	2	is	be	VBZ
cord-339919-4ko4lwjz	20	3	also	also	RB
cord-339919-4ko4lwjz	20	4	easy	easy	JJ
cord-339919-4ko4lwjz	20	5	to	to	TO
cord-339919-4ko4lwjz	20	6	dismiss	dismiss	VB
cord-339919-4ko4lwjz	20	7	high	high	JJ
cord-339919-4ko4lwjz	20	8	blood	blood	NN
cord-339919-4ko4lwjz	20	9	pressure	pressure	NN
cord-339919-4ko4lwjz	20	10	as	as	IN
cord-339919-4ko4lwjz	20	11	a	a	DT
cord-339919-4ko4lwjz	20	12	risk	risk	NN
cord-339919-4ko4lwjz	20	13	factor	factor	NN
cord-339919-4ko4lwjz	20	14	as	as	IN
cord-339919-4ko4lwjz	20	15	other	other	JJ
cord-339919-4ko4lwjz	20	16	factors	factor	NNS
cord-339919-4ko4lwjz	20	17	such	such	JJ
cord-339919-4ko4lwjz	20	18	as	as	IN
cord-339919-4ko4lwjz	20	19	underlying	underlying	JJ
cord-339919-4ko4lwjz	20	20	cardiovascular	cardiovascular	JJ
cord-339919-4ko4lwjz	20	21	or	or	CC
cord-339919-4ko4lwjz	20	22	respiratory	respiratory	JJ
cord-339919-4ko4lwjz	20	23	disease	disease	NN
cord-339919-4ko4lwjz	20	24	might	may	MD
cord-339919-4ko4lwjz	20	25	initially	initially	RB
cord-339919-4ko4lwjz	20	26	seem	seem	VB
cord-339919-4ko4lwjz	20	27	more	more	RBR
cord-339919-4ko4lwjz	20	28	likely	likely	JJ
cord-339919-4ko4lwjz	20	29	to	to	TO
cord-339919-4ko4lwjz	20	30	impact	impact	VB
cord-339919-4ko4lwjz	20	31	outcome	outcome	NN
cord-339919-4ko4lwjz	20	32	,	,	,
cord-339919-4ko4lwjz	20	33	as	as	IN
cord-339919-4ko4lwjz	20	34	they	-PRON-	PRP
cord-339919-4ko4lwjz	20	35	do	do	VBP
cord-339919-4ko4lwjz	20	36	for	for	IN
cord-339919-4ko4lwjz	20	37	other	other	JJ
cord-339919-4ko4lwjz	20	38	critical	critical	JJ
cord-339919-4ko4lwjz	20	39	illnesses	illness	NNS
cord-339919-4ko4lwjz	20	40	.	.	.
cord-339919-4ko4lwjz	21	1	However	however	RB
cord-339919-4ko4lwjz	21	2	,	,	,
cord-339919-4ko4lwjz	21	3	the	the	DT
cord-339919-4ko4lwjz	21	4	evidence	evidence	NN
cord-339919-4ko4lwjz	21	5	shown	show	VBN
cord-339919-4ko4lwjz	21	6	here	here	RB
cord-339919-4ko4lwjz	21	7	indicates	indicate	VBZ
cord-339919-4ko4lwjz	21	8	that	that	IN
cord-339919-4ko4lwjz	21	9	hypertension	hypertension	NN
cord-339919-4ko4lwjz	21	10	is	be	VBZ
cord-339919-4ko4lwjz	21	11	consistently	consistently	RB
cord-339919-4ko4lwjz	21	12	associated	associate	VBN
cord-339919-4ko4lwjz	21	13	with	with	IN
cord-339919-4ko4lwjz	21	14	severe	severe	JJ
cord-339919-4ko4lwjz	21	15	or	or	CC
cord-339919-4ko4lwjz	21	16	critical	critical	JJ
cord-339919-4ko4lwjz	21	17	illness	illness	NN
cord-339919-4ko4lwjz	21	18	,	,	,
cord-339919-4ko4lwjz	21	19	and	and	CC
cord-339919-4ko4lwjz	21	20	with	with	IN
cord-339919-4ko4lwjz	21	21	death	death	NN
cord-339919-4ko4lwjz	21	22	.	.	.
cord-339919-4ko4lwjz	22	1	There	there	EX
cord-339919-4ko4lwjz	22	2	is	be	VBZ
cord-339919-4ko4lwjz	22	3	increasing	increase	VBG
cord-339919-4ko4lwjz	22	4	understanding	understanding	NN
cord-339919-4ko4lwjz	22	5	that	that	IN
cord-339919-4ko4lwjz	22	6	severe	severe	JJ
cord-339919-4ko4lwjz	22	7	COVID-19	covid-19	JJ
cord-339919-4ko4lwjz	22	8	causes	cause	NNS
cord-339919-4ko4lwjz	22	9	considerable	considerable	JJ
cord-339919-4ko4lwjz	22	10	vascular	vascular	JJ
cord-339919-4ko4lwjz	22	11	abnormalities	abnormality	NNS
cord-339919-4ko4lwjz	22	12	including	include	VBG
cord-339919-4ko4lwjz	22	13	widespread	widespread	JJ
cord-339919-4ko4lwjz	22	14	microthrombotic	microthrombotic	JJ
cord-339919-4ko4lwjz	22	15	and	and	CC
cord-339919-4ko4lwjz	22	16	macrothrombotic	macrothrombotic	JJ
cord-339919-4ko4lwjz	22	17	events	event	NNS
cord-339919-4ko4lwjz	22	18	,	,	,
cord-339919-4ko4lwjz	22	19	renal	renal	JJ
cord-339919-4ko4lwjz	22	20	and	and	CC
cord-339919-4ko4lwjz	22	21	cardiac	cardiac	JJ
cord-339919-4ko4lwjz	22	22	failure	failure	NN
cord-339919-4ko4lwjz	22	23	.	.	.
cord-339919-4ko4lwjz	23	1	The	the	DT
cord-339919-4ko4lwjz	23	2	association	association	NN
cord-339919-4ko4lwjz	23	3	of	of	IN
cord-339919-4ko4lwjz	23	4	hypertension	hypertension	NN
cord-339919-4ko4lwjz	23	5	with	with	IN
cord-339919-4ko4lwjz	23	6	its	-PRON-	PRP$
cord-339919-4ko4lwjz	23	7	potential	potential	JJ
cord-339919-4ko4lwjz	23	8	microvascular	microvascular	JJ
cord-339919-4ko4lwjz	23	9	disease	disease	NN
cord-339919-4ko4lwjz	23	10	,	,	,
cord-339919-4ko4lwjz	23	11	with	with	IN
cord-339919-4ko4lwjz	23	12	more	more	RBR
cord-339919-4ko4lwjz	23	13	severe	severe	JJ
cord-339919-4ko4lwjz	23	14	disease	disease	NN
cord-339919-4ko4lwjz	23	15	and	and	CC
cord-339919-4ko4lwjz	23	16	poor	poor	JJ
cord-339919-4ko4lwjz	23	17	outcomes	outcome	NNS
cord-339919-4ko4lwjz	23	18	from	from	IN
cord-339919-4ko4lwjz	23	19	COVID-19	COVID-19	NNP
cord-339919-4ko4lwjz	23	20	,	,	,
cord-339919-4ko4lwjz	23	21	is	be	VBZ
cord-339919-4ko4lwjz	23	22	therefore	therefore	RB
cord-339919-4ko4lwjz	23	23	an	an	DT
cord-339919-4ko4lwjz	23	24	important	important	JJ
cord-339919-4ko4lwjz	23	25	consideration	consideration	NN
cord-339919-4ko4lwjz	23	26	.	.	.
cord-339919-4ko4lwjz	23	27	 	 	_SP
cord-339919-4ko4lwjz	24	1	Receptor	receptor	NN
cord-339919-4ko4lwjz	24	2	recognition	recognition	NN
cord-339919-4ko4lwjz	24	3	by	by	IN
cord-339919-4ko4lwjz	24	4	novel	novel	JJ
cord-339919-4ko4lwjz	24	5	coronavirus	coronavirus	NN
cord-339919-4ko4lwjz	24	6	from	from	IN
cord-339919-4ko4lwjz	24	7	Wuhan	Wuhan	NNP
cord-339919-4ko4lwjz	24	8	:	:	:
cord-339919-4ko4lwjz	24	9	an	an	DT
cord-339919-4ko4lwjz	24	10	analysis	analysis	NN
cord-339919-4ko4lwjz	24	11	based	base	VBN
cord-339919-4ko4lwjz	24	12	on	on	IN
cord-339919-4ko4lwjz	24	13	decade	decade	NN
cord-339919-4ko4lwjz	24	14	-	-	HYPH
cord-339919-4ko4lwjz	24	15	long	long	JJ
cord-339919-4ko4lwjz	24	16	structural	structural	JJ
cord-339919-4ko4lwjz	24	17	studies	study	NNS
cord-339919-4ko4lwjz	24	18	of	of	IN
cord-339919-4ko4lwjz	24	19	SARS	SARS	NNP
cord-339919-4ko4lwjz	24	20	Clinical	clinical	JJ
cord-339919-4ko4lwjz	24	21	characteristics	characteristic	NNS
cord-339919-4ko4lwjz	24	22	of	of	IN
cord-339919-4ko4lwjz	24	23	138	138	CD
cord-339919-4ko4lwjz	24	24	hospitalized	hospitalize	VBN
cord-339919-4ko4lwjz	24	25	patients	patient	NNS
cord-339919-4ko4lwjz	24	26	with	with	IN
cord-339919-4ko4lwjz	24	27	2019	2019	CD
cord-339919-4ko4lwjz	24	28	novel	novel	JJ
cord-339919-4ko4lwjz	24	29	coronavirus	coronavirus	NN
cord-339919-4ko4lwjz	24	30	-	-	HYPH
cord-339919-4ko4lwjz	24	31	infected	infect	VBN
cord-339919-4ko4lwjz	24	32	pneumonia	pneumonia	NN
cord-339919-4ko4lwjz	24	33	in	in	IN
cord-339919-4ko4lwjz	24	34	Wuhan	Wuhan	NNP
cord-339919-4ko4lwjz	24	35	Clinical	Clinical	NNP
cord-339919-4ko4lwjz	24	36	course	course	NN
cord-339919-4ko4lwjz	24	37	and	and	CC
cord-339919-4ko4lwjz	24	38	risk	risk	NN
cord-339919-4ko4lwjz	24	39	factors	factor	NNS
cord-339919-4ko4lwjz	24	40	for	for	IN
cord-339919-4ko4lwjz	24	41	mortality	mortality	NN
cord-339919-4ko4lwjz	24	42	of	of	IN
cord-339919-4ko4lwjz	24	43	adult	adult	NN
cord-339919-4ko4lwjz	24	44	inpatients	inpatient	NNS
cord-339919-4ko4lwjz	24	45	with	with	IN
cord-339919-4ko4lwjz	24	46	COVID-19	COVID-19	NNP
cord-339919-4ko4lwjz	24	47	in	in	IN
cord-339919-4ko4lwjz	24	48	Wuhan	Wuhan	NNP
cord-339919-4ko4lwjz	24	49	,	,	,
cord-339919-4ko4lwjz	24	50	China	China	NNP
cord-339919-4ko4lwjz	24	51	:	:	:
cord-339919-4ko4lwjz	25	1	a	a	DT
cord-339919-4ko4lwjz	25	2	retrospective	retrospective	JJ
cord-339919-4ko4lwjz	25	3	cohort	cohort	NN
cord-339919-4ko4lwjz	25	4	study	study	NN
cord-339919-4ko4lwjz	25	5	Clinical	clinical	JJ
cord-339919-4ko4lwjz	25	6	characteristics	characteristic	NNS
cord-339919-4ko4lwjz	25	7	of	of	IN
cord-339919-4ko4lwjz	25	8	coronavirus	coronavirus	NN
cord-339919-4ko4lwjz	25	9	disease	disease	NN
cord-339919-4ko4lwjz	25	10	2019	2019	CD
cord-339919-4ko4lwjz	25	11	in	in	IN
cord-339919-4ko4lwjz	25	12	China	China	NNP
cord-339919-4ko4lwjz	26	1	Clinical	clinical	JJ
cord-339919-4ko4lwjz	26	2	course	course	NN
cord-339919-4ko4lwjz	26	3	and	and	CC
cord-339919-4ko4lwjz	26	4	outcomes	outcome	NNS
cord-339919-4ko4lwjz	26	5	of	of	IN
cord-339919-4ko4lwjz	26	6	344	344	CD
cord-339919-4ko4lwjz	26	7	intensive	intensive	JJ
cord-339919-4ko4lwjz	26	8	care	care	NN
cord-339919-4ko4lwjz	26	9	patients	patient	NNS
cord-339919-4ko4lwjz	26	10	with	with	IN
cord-339919-4ko4lwjz	26	11	COVID-19	COVID-19	NNP
cord-339919-4ko4lwjz	26	12	.	.	.
cord-339919-4ko4lwjz	27	1	American	American	NNP
cord-339919-4ko4lwjz	27	2	Journal	Journal	NNP
cord-339919-4ko4lwjz	27	3	of	of	IN
cord-339919-4ko4lwjz	27	4	Respiratory	Respiratory	NNP
cord-339919-4ko4lwjz	27	5	and	and	CC
cord-339919-4ko4lwjz	27	6	Critical	Critical	NNP
cord-339919-4ko4lwjz	27	7	Care	Care	NNP
cord-339919-4ko4lwjz	27	8	Medicine	Medicine	NNP
cord-339919-4ko4lwjz	27	9	2020	2020	CD
cord-339919-4ko4lwjz	28	1	Novel	novel	JJ
cord-339919-4ko4lwjz	28	2	Coronavirus	Coronavirus	NNP
cord-339919-4ko4lwjz	28	3	Pneumonia	Pneumonia	NNP
cord-339919-4ko4lwjz	28	4	Emergency	Emergency	NNP
cord-339919-4ko4lwjz	28	5	Response	Response	NNP
cord-339919-4ko4lwjz	28	6	Epidemiology	Epidemiology	NNP
cord-339919-4ko4lwjz	28	7	Team	Team	NNP
cord-339919-4ko4lwjz	28	8	.	.	.
cord-339919-4ko4lwjz	29	1	Vital	vital	JJ
cord-339919-4ko4lwjz	29	2	surveillances	surveillance	NNS
cord-339919-4ko4lwjz	29	3	:	:	:
cord-339919-4ko4lwjz	29	4	the	the	DT
cord-339919-4ko4lwjz	29	5	epidemiological	epidemiological	JJ
cord-339919-4ko4lwjz	29	6	characteristics	characteristic	NNS
cord-339919-4ko4lwjz	29	7	of	of	IN
cord-339919-4ko4lwjz	29	8	an	an	DT
cord-339919-4ko4lwjz	29	9	outbreak	outbreak	NN
cord-339919-4ko4lwjz	29	10	of	of	IN
cord-339919-4ko4lwjz	29	11	2019	2019	CD
cord-339919-4ko4lwjz	29	12	novel	novel	JJ
cord-339919-4ko4lwjz	29	13	coronavirus	coronavirus	NN
cord-339919-4ko4lwjz	29	14	diseases	disease	NNS
cord-339919-4ko4lwjz	29	15	(	(	-LRB-
cord-339919-4ko4lwjz	29	16	COVID-19)-China	COVID-19)-China	NNP
cord-339919-4ko4lwjz	29	17	Baseline	baseline	JJ
cord-339919-4ko4lwjz	29	18	characteristics	characteristic	NNS
cord-339919-4ko4lwjz	29	19	and	and	CC
cord-339919-4ko4lwjz	29	20	outcomes	outcome	NNS
cord-339919-4ko4lwjz	29	21	of	of	IN
cord-339919-4ko4lwjz	29	22	1591	1591	CD
cord-339919-4ko4lwjz	29	23	patients	patient	NNS
cord-339919-4ko4lwjz	29	24	infected	infect	VBN
cord-339919-4ko4lwjz	29	25	with	with	IN
cord-339919-4ko4lwjz	29	26	SARS	SARS	NNP
cord-339919-4ko4lwjz	29	27	-	-	HYPH
cord-339919-4ko4lwjz	29	28	CoV-2	CoV-2	NNP
cord-339919-4ko4lwjz	29	29	admitted	admit	VBD
cord-339919-4ko4lwjz	29	30	to	to	IN
cord-339919-4ko4lwjz	29	31	ICUs	ICUs	NNP
cord-339919-4ko4lwjz	29	32	of	of	IN
cord-339919-4ko4lwjz	29	33	the	the	DT
cord-339919-4ko4lwjz	29	34	Lombardy	Lombardy	NNP
cord-339919-4ko4lwjz	29	35	region	region	NN
cord-339919-4ko4lwjz	29	36	Status	status	NN
cord-339919-4ko4lwjz	29	37	of	of	IN
cord-339919-4ko4lwjz	29	38	hypertension	hypertension	NN
cord-339919-4ko4lwjz	29	39	in	in	IN
cord-339919-4ko4lwjz	29	40	China	China	NNP
cord-339919-4ko4lwjz	29	41	:	:	:
cord-339919-4ko4lwjz	29	42	results	result	NNS
cord-339919-4ko4lwjz	29	43	from	from	IN
cord-339919-4ko4lwjz	29	44	the	the	DT
cord-339919-4ko4lwjz	29	45	China	China	NNP
cord-339919-4ko4lwjz	29	46	Hypertension	Hypertension	NNP
cord-339919-4ko4lwjz	29	47	Survey	Survey	NNP
cord-339919-4ko4lwjz	29	48	Prevalence	prevalence	NN
cord-339919-4ko4lwjz	29	49	and	and	CC
cord-339919-4ko4lwjz	29	50	control	control	NN
cord-339919-4ko4lwjz	29	51	of	of	IN
cord-339919-4ko4lwjz	29	52	hypertension	hypertension	NN
cord-339919-4ko4lwjz	29	53	in	in	IN
cord-339919-4ko4lwjz	29	54	the	the	DT
cord-339919-4ko4lwjz	29	55	general	general	JJ
cord-339919-4ko4lwjz	29	56	practice	practice	NN
cord-339919-4ko4lwjz	29	57	in	in	IN
cord-339919-4ko4lwjz	29	58	Italy	Italy	NNP
cord-339919-4ko4lwjz	29	59	:	:	:
cord-339919-4ko4lwjz	30	1	updated	update	VBN
cord-339919-4ko4lwjz	30	2	analysis	analysis	NN
cord-339919-4ko4lwjz	30	3	of	of	IN
cord-339919-4ko4lwjz	30	4	a	a	DT
cord-339919-4ko4lwjz	30	5	large	large	JJ
cord-339919-4ko4lwjz	30	6	database	database	NN
cord-339919-4ko4lwjz	30	7	Prevalence	prevalence	NN
cord-339919-4ko4lwjz	30	8	of	of	IN
cord-339919-4ko4lwjz	30	9	comorbidities	comorbiditie	NNS
cord-339919-4ko4lwjz	30	10	and	and	CC
cord-339919-4ko4lwjz	30	11	its	-PRON-	PRP$
cord-339919-4ko4lwjz	30	12	effects	effect	NNS
cord-339919-4ko4lwjz	30	13	in	in	IN
cord-339919-4ko4lwjz	30	14	coronavirus	coronavirus	NN
cord-339919-4ko4lwjz	30	15	disease	disease	NN
cord-339919-4ko4lwjz	30	16	2019	2019	CD
cord-339919-4ko4lwjz	30	17	patients	patient	NNS
cord-339919-4ko4lwjz	31	1	:	:	:
cord-339919-4ko4lwjz	31	2	A	a	DT
cord-339919-4ko4lwjz	31	3	systematic	systematic	JJ
cord-339919-4ko4lwjz	31	4	review	review	NN
cord-339919-4ko4lwjz	31	5	and	and	CC
cord-339919-4ko4lwjz	31	6	meta	meta	NNP
cord-339919-4ko4lwjz	31	7	-	-	HYPH
cord-339919-4ko4lwjz	31	8	analysis	analysis	NN
cord-339919-4ko4lwjz	31	9	Are	be	VBP
cord-339919-4ko4lwjz	31	10	patients	patient	NNS
cord-339919-4ko4lwjz	31	11	with	with	IN
cord-339919-4ko4lwjz	31	12	hypertension	hypertension	NN
cord-339919-4ko4lwjz	31	13	and	and	CC
cord-339919-4ko4lwjz	31	14	diabetes	diabetes	NN
cord-339919-4ko4lwjz	31	15	mellitus	mellitus	NN
cord-339919-4ko4lwjz	31	16	at	at	IN
cord-339919-4ko4lwjz	31	17	increased	increase	VBN
cord-339919-4ko4lwjz	31	18	risk	risk	NN
cord-339919-4ko4lwjz	31	19	for	for	IN
cord-339919-4ko4lwjz	31	20	COVID-19	covid-19	JJ
cord-339919-4ko4lwjz	31	21	infection	infection	NN
cord-339919-4ko4lwjz	31	22	?	?	.
cord-339919-4ko4lwjz	32	1	Exclusive	exclusive	JJ
cord-339919-4ko4lwjz	32	2	:	:	:
cord-339919-4ko4lwjz	32	3	deaths	death	NNS
cord-339919-4ko4lwjz	32	4	of	of	IN
cord-339919-4ko4lwjz	32	5	NHS	NHS	NNP
cord-339919-4ko4lwjz	32	6	staff	staff	NN
cord-339919-4ko4lwjz	32	7	from	from	IN
cord-339919-4ko4lwjz	32	8	covid-19	covid-19	NNP
cord-339919-4ko4lwjz	32	9	analysed	analyse	VBN